SEC FORM 4
$3,654,000.00
Amneal Pharmaceuticals, Inc. (AMRX)
Sale of 210,000 shares at $17.40 per share.
Reporting Person Daly Jason B. · Officer Title EVP, Chief Legal Officer · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001628280-26-056754 · filed 2026-08-13 · View filing →